Topic: Next Gen Sequencing

Top 25 Biotech CEOs of 2020 - Soheil Shams

Since the advent of advanced genomics, and the subsequent rise of automation, the data generated in clinical testing and research sees a 100 fold increase each year making the storage, security and management of patient data quite a daunting task for companies to mine the data to find the factors that drive a patient’s disease. That’s where BioDiscovery comes in. Their flagship solution NxClinical, is a unique software tool for integrated analysis of copy number, sequence variants, and allelic changes obtained from multiple technologies. The solution combines NGS and Array data through advanced mining and filtering techniques which allows the data to be clear and digestible for clinicians. 

BioDiscovery launches the NxClinical Center of Excellence initiative with Victorian Clinical Genetics Services as its first partner

BioDiscovery launches the NxClinical Center of Excellence initiative with Victorian Clinical Genetics Services as its first partner

BioDiscovery’s NxClinical software augments PerkinElmer Genomics newborn screening and genomic testing services in labs around the world

PerkinElmer Genomics has selected BioDiscovery's NxClinical software as its choice for genomic data analysis for its services.

BioDiscovery releases Nexus Copy Number 10.0, a single solution for copy number estimation from arrays, WES, WGS, shallow, and targeted sequencing

Nexus Copy Number 10.0 is a highly robust, intuitive, and multi-platform software for both copy number calling and downstream statistical analyses. A key feature of Nexus Copy Number is its ability to derive high quality copy number calls from many flavors of NGS (whole exome, whole genome, shallow, targeted panel, and normal depth of coverage sequencing).

BioDiscovery launches NxClinical 4.1, a comprehensive system allowing interpretation of variants of any size from SNVs to large CNVs

NxClinical 4.1 is a unique software solution for integration of copy number, sequence variants, and allelic changes obtained from microarray and NGS technologies. NxClinical 4.1 allows combined analysis and interpretation of all genomic variants on a single, platform agnostic system.

BioDiscovery releases Nexus Copy Number 9.0 with improved copy number estimation from NGS, including targeted panels and shallow sequencing

The new features in Nexus Copy Number 9.0 really enhance the usability of WES, WGS, targeted panels and low-pass sequencing for copy number analysis.

BioDiscovery releases Nexus Copy Number 8.0 with cutting-edge features: estimation of copy number and allelic events from NGS data

Nexus Copy Number 8.0 is derivation of copy number from NGS results. BAM (pooled reference), detects copy number from WES, WGS, and targeted NGS panels.